A double-blind, placebo controlled study investigating efficacy of botulinum toxin type A (Dysport®) in MS related overactive bladder syndrome (OAB): Provisional 36 week results.
Finney S1, Patrick K1, Stewart L1 1. Western General Hospital
| Abstract 130 |
| Overactive Bladder - Basic Science and Clinical Practice:Main Auditorium
Scientific Podium Poster Session 14 |
| Friday 1st December 2006 |
| 09:52 - 10:00 |
|